Literature DB >> 17146657

At-risk patients still predisposed for myocardial infarction by coxibs.

Arja Helin-Salmivaara, Jaana E Martikainen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17146657     DOI： 10.1007/s00228-006-0232-x

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  3 in total

1.  NSAID use and the risk of hospitalization for first myocardial infarction in the general population: a nationwide case-control study from Finland.

Authors:  Arja Helin-Salmivaara; Arja Virtanen; Risto Vesalainen; Juha M Grönroos; Timo Klaukka; Juhana E Idänpään-Heikkilä; Risto Huupponen
Journal:  Eur Heart J       Date:  2006-05-26       Impact factor: 29.983

Review 2.  Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

Authors:  Patricia McGettigan; David Henry
Journal:  JAMA       Date:  2006-09-12       Impact factor: 56.272

3.  Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction.

Authors:  Frank Andersohn; Samy Suissa; Edeltraut Garbe
Journal:  Circulation       Date:  2006-04-17       Impact factor: 29.690
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.